Jun 29, 2017

Trump names Surgeon General nominee

Darron Cummings / AP

President Trump has nominated Jerome M. Adams to serve as the next U.S. Surgeon General. He currently serves as Indiana State Health Commissioner, a position VP Mike Pence appointed him to, and used to work as an anesthesiologist at the Indiana University School of Medicine. (That would make him the second top health official with ties to Pence, the first being Seema Verma, who administers Medicare and Medicaid, per Stat.)

Adams has promoted a needle exchange program in Indiana to reduce the spread of diseases among intravenous drug users in the state, which suffers from the opioid epidemic.

The resume: BS in Biochemistry and BA in Biopsychology from the University of Maryland Baltimore County, MPH from University of California at Berkeley, MD from Indiana University School of Medicine.

His response to being nominated? He is "honored."

Go deeper

The month coronavirus shook the world

Illustration: Sarah Grillo/Axios

It’s already hard to envision the world we lived in one month ago.

Flashback: A WHO report from March 1 shows a total of 7,169 coronavirus cases outside of China, with just seven countries having recorded even a single fatality and the total death toll under 3,000, including China.

Go deeperArrow2 mins ago - World

Coronavirus could hit developing countries hardest

Disinfecting in Dakar, Senegal. Photo: John Wessels/AFP via Getty Images

The coronavirus is spreading most widely in countries that should be among the best equipped to handle it. There's no reason to expect that to remain the case.

Where things stand: 88% of new coronavirus cases confirmed on Wednesday came within the OECD club of wealthy nations, which together account for just 17% of the world's population. While that data is based on uneven and inadequate testing, Europe and North America are clearly in the eye of the storm.

Go deeperArrow6 mins ago - World

The Humanity First push for a coronavirus vaccine

Illustration: Aïda Amer/Axios

Policy responses to the global coronavirus crisis have been every-country-for-itself and — in the case of the U.S. and China — tinged with geopolitics.

The flipside: The scientific work underway to understand the virus and develop a vaccine has been globalized on an unprecedented scale.

Go deeperArrow14 mins ago - World